Biomarkers
DRAGEN biomarker support is tabulated below. Please refer to the respective sections for details on requirements and how to configure each module.
WES T/N
WES T/O
WGS T/N
WGS T/O
[1] All Tumor/Normal workflows automatically perform mutational signatures analysis with no additional options required.
[2] WES sequences ~1% of the genome compared to WGS, resulting in ~1% of the somatic mutations available for analysis. While analysis execution is possible, it is not recommended; results are likely not reliable with such limited input.
Last updated
Was this helpful?
